|
Real-time Estimate
Tradegate
05:10:36 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 36.70 EUR | +0.27% |
|
-1.06% | -8.33% |
| 09-15 | Sanofi Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 01:50 PM | |
| 09-15 | Sanofi : Deutsche Bank reiterates its Buy rating | ZD |
| Market Cap | 88.91B 103B 84.07B 76.11B 143B 9,846B 144B 1,003B 386B 4,992B 386B 377B 15,922B | P/E 2026 * |
11.8x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 100B 116B 94.91B 85.93B 161B 11,115B 162B 1,133B 436B 5,636B 435B 426B 17,974B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.92x |
| Free-Float |
88.34% | Yield 2026 * |
5.73% | Yield 2027 * | 6.06% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNY | Delayed | |
CBOE
| SNY | Real-time | |
|
Mexican S.E.
| SNY N | End-of-day quote | |
|
Tradegate
| SNW2 | Real-time | |
|
Deutsche Boerse AG
| SNW2 | Delayed | |
|
Börse Stuttgart
| SNW2 | Delayed | |
|
Boerse Muenchen
| SNW2 | Real-time |
Last Transcript: Sanofi
| 1 week | -1.61% | ||
| Current month | -3.68% | ||
| 1 month | -2.66% | ||
| 3 months | -3.17% | ||
| 6 months | -3.68% | ||
| Current year | -10.29% |
| 1 week | 36.4 |  | 37.6 |
| 1 month | 36.4 | | 39.6 |
| 3 years | 35.6 | | 55 |
| 5 years | 35.6 | | 55 |
| 10 years | 30.6 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.27% | -1.06% | -6.63% | -28.24% | 103B | |
| -0.19% | +1.09% | +51.85% | +97.36% | 1,013B | |
| +0.33% | -0.71% | +50.62% | +65.50% | 644B | |
| +0.49% | +5.73% | +20.88% | +72.92% | 465B | |
| +0.54% | +4.49% | +40.60% | +40.84% | 352B | |
| +0.81% | +2.99% | +18.70% | +24.97% | 264B | |
| +0.53% | +4.86% | +7.67% | +13.87% | 253B | |
| -1.53% | -4.46% | +36.90% | +44.08% | 203B | |
| +0.39% | -3.91% | -22.70% | -57.32% | 188B | |
| -0.08% | -0.23% | +30.00% | +93.34% | 181B | |
| Average | +0.36% | -1.08% | +22.79% | +36.73% | 395.97B | |
| Weighted average by Cap. | +0.69% | +0.01% | +33.81% | +57.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.65B 55.01B 45.06B 40.79B 76.56B 5,277B 77.13B 538B 207B 2,676B 207B 202B 8,533B | 50.64B 58.47B 47.89B 43.36B 81.37B 5,608B 81.98B 571B 220B 2,844B 220B 215B 9,069B |
| Net income | 7.48B 8.63B 7.07B 6.4B 12.01B 828B 12.1B 84.35B 32.45B 420B 32.42B 31.7B 1,339B | 8.87B 10.24B 8.39B 7.59B 14.25B 982B 14.36B 100B 38.5B 498B 38.46B 37.61B 1,588B |
| Net Debt | 11.46B 13.23B 10.84B 9.81B 18.42B 1,269B 18.56B 129B 49.77B 644B 49.71B 48.61B 2,053B | 8.34B 9.62B 7.88B 7.14B 13.39B 923B 13.49B 94.06B 36.19B 468B 36.15B 35.35B 1,493B |
| Date | Price | Change |
|---|---|---|
| 26-09-16 | €36.80 | +0.55% |
| 26-09-15 | €36.60 | -2.14% |
| 26-09-14 | €37.40 | +1.63% |
| 26-09-11 | €36.80 | +0.55% |
| 26-09-10 | €36.60 | -0.54% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
